BigMike305
Registered
- Joined
- Dec 16, 2024
- Messages
- 934
- Reaction score
- 1,352
- Points
- 101
Interesting study on LPa lowering and outcomes in patients w established cardiovascular disease
newsroom.heart.org
Would be nice if they could do a study in people without preexisting cardiovascular disease
Lp(a) HORIZON trial: Lp(a) fell by 78%, but cardiovascular outcomes unexpectedly neutral
Research Highlights: In the 7-year, phase III, multicenter, international Lp(a) HORIZON trial, the novel medication pelacarsen lowered Lp(a) levels by a mean of 78% in a trial with more than 8,300 adults with cardiovascular disease in 42 countries. ...
Would be nice if they could do a study in people without preexisting cardiovascular disease
